Literature DB >> 6090947

Transposition without duplication of infecting bacteriophage Mu DNA.

R M Harshey.   

Abstract

Most models of DNA transposition invoke replication of the transposable element, but it is not clear whether a 'co-integrate' is an obligatory intermediate in the pathway leading to the production of simple insertions during transposition. Such an intermediate can be accounted for only by a replicative transposition scheme. Bacteriophage Mu is a temperate phage that can either lysogenize or lyse its host, and it encodes at least two modes of transposition as judged by the end-products generated by the process. During the lytic development of the integrated prophage, co-integrates are the predominant end-products; transposition is coupled to replication during this phase. A small number of simple insertions are also produced during the lytic growth, but during transposition from the infecting phage into the host chromosome, simple insertions are the main end-products. Conditions can be found where the choice between the two kinds of end-products depends on a delicate balance between the essential transposition functions encoded by Mu. Experiments have suggested that the simple insertions which arise during transposition from the infecting phage may do so without Mu DNA replication. Here I demonstrate using an infecting phage with completely methylated DNA, a dam- (DNA adenine methylase) host and a combination of restriction enzymes that can cut either fully methylated or unmethylated DNA but not hemi-methylated DNA, that transposition of the phage DNA into the host chromosome does not involve a duplication of its DNA. This result may also have significance for other transposons that do not appear to go through a co-integrate intermediate during transposition.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090947     DOI: 10.1038/311580a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  16 in total

Review 1.  Handoff from recombinase to replisome: insights from transposition.

Authors:  H Nakai; V Doseeva; J M Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

2.  DNA repair by the cryptic endonuclease activity of Mu transposase.

Authors:  Wonyoung Choi; Rasika M Harshey
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-18       Impact factor: 11.205

3.  Phage Mu transposase: deletion of the carboxy-terminal end does not abolish DNA-binding activity.

Authors:  M Betermier; R Alazard; F Ragueh; E Roulet; A Toussaint; M Chandler
Journal:  Mol Gen Genet       Date:  1987-11

4.  Chromosomal integration mechanism of infecting mu virion DNA.

Authors:  T K Au; Pushpa Agrawal; Rasika M Harshey
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

5.  In vivo mutagenesis of bacteriophage Mu transposase.

Authors:  A Toussaint; L Desmet; M Faelen; R Alazard; M Chandler; M Pato
Journal:  J Bacteriol       Date:  1987-12       Impact factor: 3.490

6.  Mu transpososome and RecBCD nuclease collaborate in the repair of simple Mu insertions.

Authors:  Wonyoung Choi; Sooin Jang; Rasika M Harshey
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

7.  Replication forks of Escherichia coli are not the preferred sites for lysogenic integration of bacteriophage Mu.

Authors:  S Sivan; A Zaritsky; V Kagan-Zur
Journal:  J Bacteriol       Date:  1988-07       Impact factor: 3.490

Review 8.  Transposable Phage Mu.

Authors:  Rasika M Harshey
Journal:  Microbiol Spectr       Date:  2014-10

Review 9.  The Mu gem operon: its role in gene expression, recombination and cell cycle.

Authors:  P Ghelardini; R La Valle; L Paolozzi
Journal:  Genetica       Date:  1994       Impact factor: 1.082

Review 10.  Application of the bacteriophage Mu-driven system for the integration/amplification of target genes in the chromosomes of engineered Gram-negative bacteria--mini review.

Authors:  Valerii Z Akhverdyan; Evgueni R Gak; Irina L Tokmakova; Nataliya V Stoynova; Yurgis A V Yomantas; Sergey V Mashko
Journal:  Appl Microbiol Biotechnol       Date:  2011-06-23       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.